Cochlear Limited (COH) - Analysis

265.17999 AUD

2.79

1.06%

Last update Dec 15, 11:00 AM AEDT

Main market

Day range

265.17999

261.60999

265.35001

Previous close

262.39001

Open

263.54999

Access this stock data via API

Cochlear Limited

265.18

2.79

1.06%

Analysis

Revenue estimate	Current year (Jun 2026)	Next year (Jun 2027)
Number of Analysts	15	15
Avg. estimate	2.60B	2.88B
Low estimate	2.56B	2.72B
High estimate	2.73B	3.10B
Last year sales	2.34B	2.60B
Sales growth	0.11	0.11

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current year (Jun 2026)	Next year (Jun 2027)
Up last 7 days	0	0
Up last 30 days	0	0
Down last 7 days	0	0
Down last 30 days	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
Piper Sandler	Oct 05, 2017	Downgrade
Wolfe Research	Oct 03, 2017	Downgrade
Jefferies	Jul 31, 2017	Downgrade
Buckingham Research	Jun 26, 2017	Upgrade
Deutsche Bank	May 15, 2017	Upgrade
Goldman Sachs	May 10, 2017	Upgrade
Goldman Sachs	Feb 02, 2017	Upgrade
Evercore ISI Group	Feb 01, 2017	Upgrade
CLSA	Jan 25, 2017	Downgrade
Guggenheim	Sep 30, 2016	Initiates
B of A Securities	Aug 10, 2016	Upgrade
Telsey Advisory Group	Aug 05, 2016	Upgrade
Baird	Jul 18, 2016	Upgrade
Stifel	May 17, 2016	Assumes
William Blair	Apr 07, 2016	Upgrade
Wolfe Research	Jan 27, 2016	Upgrade
BB&T Capital	Jan 04, 2016	Upgrade
Wells Fargo	Oct 22, 2015	Assumes
Renaissance Capital	Jun 05, 2015	Upgrade
BB&T Capital	May 27, 2015	Initiates
Standpoint Research	Mar 02, 2015	Downgrade
B of A Securities	Jun 25, 2014	Downgrade
William Blair	Jun 20, 2014	Downgrade
HSBC	Jun 20, 2014	Downgrade
Cantor Fitzgerald	Jan 24, 2014	Downgrade
Standpoint Research	Jan 23, 2014	Upgrade
Standpoint Research	Nov 26, 2013	Downgrade
Standpoint Research	Oct 23, 2013	Upgrade
Lazard	Jun 25, 2013	Downgrade
Morgan Stanley	May 21, 2013	Downgrade

Access /analyst_ratings/light data via our API — starting from the Ultra plan.